Integrated Nanotherapeutics Inc.
Chris Tam, PhD has a diverse work experience in the fields of advanced therapies, nanotherapeutics, and medical education. Chris is currently involved with the Creative Destruction Lab as part of the CDL-Vancouver Advanced Therapies program. In 2015, they became the Chief Executive Officer of Integrated Nanotherapeutics Inc. Prior to that, they held roles at The University of British Columbia, including Adjunct Faculty in the MD Undergraduate Program and Senior Research Associate. Chris also worked as a Postdoctoral Fellow at the Centre for Molecular Medicine and Therapeutics from 2005 to 2008.
Chris Tam, PhD pursued their education at McGill University from 1994 to 1997, obtaining a Bachelor of Science (BSc) degree in Biochemistry. Continuing their academic career, they then attended the University of Alberta from 2000 to 2005, earning a Doctor of Philosophy (PhD) degree in Cell Biology.
This person is not in any teams
Integrated Nanotherapeutics Inc.
Integrated Nanotherapeutics Inc. is a biopharmaceutical company dedicated to the development of novel drugs in the areas of cancer and autoimmunity, including diabetes, where there is significant unmet medical need for therapeutic agents with improved activity. Our proprietary technologies allow the incorporation of any compound in lipid nanoparticle delivery systems and thus extend the benefits of delivery systems to virtually any therapeutic and diagnostic agent. We envision that many existing drugs or agents can be made much safer and more effective using our technologies.